White label ELPA - ClinicalTrials.eu

Study of deupsilocin besilate (CYB003) in adults with major depressive disorder comparing two doses against placebo

Recruiting

3 1
Study on the Use of 18F-PI-2620 for Patients with Progressive Supranuclear Palsy and Parkinson’s Disease

Recruiting

2 1 1
Investigated Diseases:
- Progressive supranuclear palsy
- Parkinson’s disease
Investigated Drugs:
- Izaflortaucipir (18F)
Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Recruiting

2 1
Investigated Drugs:
- LY3537031
+1
Randomized Study of INCB161734 Plus Standard Chemotherapy Drug Combination in Untreated KRAS G12D Metastatic Pancreatic Ductal Adenocarcinoma Patients

Recruiting

3 1 1
Investigated Drugs:
+6
A Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety

Recruiting

3 1
Investigated Diseases:
- Metabolic dysfunction-associated steatohepatitis
Investigated Drugs:
- BI 456906
- SURVODUTIDE
+6
A Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis

Recruiting

3 1
Investigated Diseases:
- Metabolic dysfunction-associated steatohepatitis
Investigated Drugs:
- BI 456906
- SURVODUTIDE
+6
A Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma

Recruiting

2 1
Investigated Drugs:
- LY3537031
A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Recruiting

3 1 1
Investigated Drugs:
- Depemokimab
- Salbutamol Sulfate
+2
A Study of Felzartamab for Kidney Transplant Patients with Late Isolated Microvascular Inflammation

Recruiting

2 1 1
Investigated Diseases:
- Renal transplant
Investigated Drugs:
- Felzartamab
- Sodium Chloride
Study of Baricitinib in Children Aged 1 to 17 Hospitalized with COVID-19

Recruiting

3 1 1
Investigated Diseases:
- COVID-19
Investigated Drugs:
- Baricitinib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies